bristol-myers glp-1 receptor agonist products Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Agonists: A Multidisciplinary Expert Consensus Frontiers | GLP-1 Receptor Agonists:
Description
doi: 10.1111/j.1365-2125.2008.03221.x
2 Enhanced glycaemic control is crucial for HF patients with T2D, who face increased cardiovascular risks
Gaining insight into the complex mechanisms through which GLP-1RAs produce their anti-inflammatory effects will improve our understanding of their therapeutic potential and facilitate the creation of new anti-inflammatory approaches
Y., Chien, K
2024 Sep 18;9(1):234
